Table 1.
Key pricing strategies used by governments in APAC for reimbursed prescription medications.
| Australia | Bangladesh | China | Hong Kong | India | Indonesia | Japan | Malaysia | New Zealand | Singapore | South Korea | Taiwan | Thailand | The Philippines | Vietnam* | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strategy | Internal Reference Pricing | X | X | X | X | X | X | |||||||||
| External Reference Pricing | X | X | X | X | X | X | ||||||||||
| Special Pricing Agreements | X | X | X | X | X | |||||||||||
| Pharmacoeconomic Evaluation | X | X | X | X | X | |||||||||||
| Cost Plus pricing | X | X | X | X | ||||||||||||
| Price Maintenance Premium | X | |||||||||||||||
| Tendering and Negotiations | X | X | X | X | X | X | X | X | X | X | X | X |
* Vietnam uses these strategies only to regulate prices